山东大学学报(医学版) ›› 2017, Vol. 55 ›› Issue (4): 76-81.doi: 10.6040/j.issn.1671-7554.0.2016.782
李雪1,2,李栋2,时庆2,周盼盼2,鞠秀丽1,2
LI Xue1,2, LI Dong2, SHI Qing2, ZHOU Panpan2, JU Xiuli1,2
摘要: 目的 检测CD4+CD25+FoxP3+调节性T细胞(Treg)在儿童急性B淋巴细胞白血病(pre-B ALL)外周血样本中的比例,探讨Helios基因在pre-B ALL外周血Treg细胞中的功能。 方法 ALL组选取10例初发pre-B ALL外周血标本,对照组选取6例行骨关节病手术并排除肿瘤、血液系统、免疫系统疾病的患儿外周血标本;采用流式细胞术检测Treg细胞在pre-B ALL 中CD4+细胞的比例,通过定量PCR技术检测Helios、FoxP3及相关转录抑制因子在ALL中CD4+CD25+Treg细胞中的表达;通过慢病毒转染和siRNA技术在Treg细胞中调节Helios表达,检测Tregs免疫抑制功能的变化。 结果 ALL组中CD4+CD25+FoxP3+细胞占CD4+T细胞比例[(6.16±0.79)%]显著高于对照组[(2.62±0.34)%](P=0.005);Helios、FoxP3、TGF-β1 mRNA在ALL患者Treg细胞中上调表达;Helios基因的异常表达与Treg细胞的免疫抑制功能呈正相关。 结论 儿童pre-BALL发病过程中,免疫功能异常与Treg细胞数量异常相关。其中Helios基因的异常表达可通过影响Treg细胞的免疫抑制功能,间接影响白血病患儿的免疫调控。Helios作为靶基因可能对以Treg细胞为主的免疫治疗具有治疗意义。
中图分类号:
[1] Pui CH, Mullighan CG, Evans WE, et al. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?[J]. Blood, 2012, 120(6): 1165-1174. [2] Liu W, Putnam AL, Xu YZ, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells[J]. J Exp Med, 2006, 203(7): 1701-1711. [3] Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin(IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells[J]. J Exp Med, 2006, 203(7): 1693-1700. [4] Beyer M, Schultze JL. Regulatory T cells in cancer[J]. Blood, 2006, 108(3): 804-811. [5] Whiteside TL. Induced regulatory T cells in inhibitory microenvironments created by cancer[J]. Expert Opin Biol Ther, 2014, 14(10): 1411-1425. [6] Jak M, Mous R, Remmerswaal EB, et al. Enhanced formation and survival of CD4+CD25highFoxP3+T-cells in chronic lymphocytic leukemia[J]. Leuk Lymphoma, 2009, 50(5): 788-801. [7] Gottschalk RA, Corse E, Allison JP. Expression of Helios in peripherally induced FoxP3+ regulatory T cells[J]. J Immunol, 2012, 188(3): 976-980. [8] Thornton AM, Korty PE, Tran DQ, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced FoxP3+T regulatory cells[J]. J Immunol, 2010, 184(7): 3433-3441. [9] Eyad E, May AS, Belal C. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP[J]. Oncotarget, 2015, 6(24): 20026-20036. [10] Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance[J]. Cell, 2008, 133(5): 775-787. [11] Byrne WL, Mills KH, Lederer JA, et al. Targeting regulatory T cells in cancer[J]. Cancer Res, 2011, 71(22): 6915-6920. [12] 李强, 蔡大幸, 陈光,等. 白癜风患者外周血CD4+CD25+Foxp3+调节性T细胞的检测及意义[J]. 山东大学学报(医学版), 2012, 50(1): 133-135. LI Qiang, CAI Daxing, CHEN Guang, et al. Detection and significance of CD4+CD25+Foxp3+ regulatory T cells in the peripheral blood of patients with vitiligo[J]. Journal of Shandong University(Health Science), 2012, 50(1): 133-135. [13] Fujisaki J, Wu J, Carlson AL, et al. In vivo imaging of Tregs providing immune privilege to the hematopoietic stem cell niche[J]. Nature, 2013, 474(7350): 216-219. [14] Idris SZ, Hassan N, Lee LJ, et al. Increased regulatory T cells in acute lymphoblastic leukemia patients[J]. Hematology, 2015, 20(9): 523-529. [15] Feuerer M, Hill JA, Mathis D, et al. FoxP3+ regulatory T cells: differentiation, specification, subphenotypes[J]. Nat Immunol, 2009, 10(7): 689-695. [16] Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells[J]. Immunity, 2013, 38(3): 414-423. [17] Teh PP, Vasanthakumar A, Kallies A. Development and function of effector regulatory T cells[J]. Prog Mol Biol Transl Sci, 2015, 136: 155-174. [18] Sebastian M, Lopez-Ocasio M, Metidji A, et al. Helios controls a limited subset of regulatory T cell functions[J]. J Immunol, 2016, 196(1): 144-155. [19] Jakub G, Dennis LG, Karolina G, et al. FoxP3, Helios, and SATB1: Roles and relationships in regulatory T cells[J]. Int Immunopharmacol, 2013, 16(3): 343-347. [20] Baine I, Basu S, Ames R, et al. Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells[J]. J Immunol, 2013, 190(3): 1008-1016. [21] Amit G, Sarfaraz H, Gabor I, et al. The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus[J]. Arthritis Rheum, 2013, 65(11): 2898-2906. [22] Kim HJ, Barnitz RA, Kreslavsky T, et al. Stable inhibitory activity of regulatory T cells requires the transcription factor helios[J]. Science, 2015, 350(6258): 334-339. [23] Singh K, Hjort M, Thorvaldson L, et al. Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice[J]. Sci Rep, 2015, 5: 7767. |
[1] | 席福立,张梅. MicroRNA-34a在心肌纤维化过程中对SH2B3的表达调控[J]. 山东大学学报(医学版), 2016, 54(2): 6-10. |
[2] | 李秀华, 李晓丽, 段瑞生, 朱梅佳, 曹莉莉, 李衍滨, 王思, 岳龙涛, 马庆海, 刘菲. 1,25(OH)2D3诱导实验性自身免疫性重症肌无力大鼠免疫耐受的机制[J]. 山东大学学报(医学版), 2015, 53(8): 5-10. |
[3] | 张蓬, 岳龙涛, 李亨, 张民, 王聪聪, 段瑞生, 窦迎春. 血脂康对实验性自身免疫性神经炎的治疗潜能[J]. 山东大学学报(医学版), 2015, 53(2): 1-5. |
[4] | 黄艳, 旷昕, 熊花, 刘鑫, 罗晓青, 刘斌. 柴朴汤调控VEGF、TGF-β1的表达对哮喘大鼠气道重塑的影响[J]. 山东大学学报(医学版), 2014, 52(S1): 14-17. |
[5] | 田艳, 侯善荣, 刘建立, 孙兴盛, 黄丽红. 不同剂量阿托伐他汀对扩张性心肌病大鼠心肌TGF-β1及心脏结构的影响[J]. 山东大学学报(医学版), 2014, 52(9): 6-10. |
[6] | 李燕, 谢敏, 史小玲, 王晓燕, 唐利, 钟森, 陈庄. HSP70/CD80 DNA疫苗通过调节Th1/Th2/Treg/Th17细胞对小鼠急性哮喘的抑制作用[J]. 山东大学学报(医学版), 2014, 52(10): 20-24. |
[7] | 王介忠1,韩波1,高聆2,杨文巍1,刘奉琴1,吕建利1,赵立健1 . CD40siRNA对EAM大鼠的作用及其对CD4+CD25+Treg的影响[J]. 山东大学学报(医学版), 2014, 52(1): 1-4. |
[8] | 周秉侠1,郭淑兰1,许艳静2. FOXP3在玫瑰糠疹、扁平苔藓、大斑块型副银屑病及蕈样肉芽肿中的表达及意义[J]. 山东大学学报(医学版), 2012, 50(2): 102-105. |
[9] | 李强1,2,蔡大幸1,陈光3,刘继峰4,李春阳1. 白癜风患者外周血CD4+CD25+ Foxp3+调节性T细胞的检测及意义[J]. 山东大学学报(医学版), 2012, 50(1): 133-. |
[10] | 郭鹏1, 刘传方2, 赵雯3. 人脐带沃顿胶间充质干细胞对重型再生障碍性贫血调节性T细胞及Foxp3基因的影响[J]. 山东大学学报(医学版), 2011, 49(9): 71-. |
[11] | 曹霞,王莲莲,罗希. 妊娠期高血压疾病妇女外周血调节性T细胞和辅助性T细胞表达分析[J]. 山东大学学报(医学版), 2011, 49(6): 137-139. |
[12] | 刘光英1,李小娜1,张娜1,王功朝1,2. 化疗对食管癌患者外周血CD4+CD25+调节性T细胞的影响[J]. 山东大学学报(医学版), 2010, 48(6): 104-. |
[13] | 于渊1,李岩1,荣风年2,梁婧1,刘晓琳1,王福立1. 自体CIK细胞治疗对卵巢癌调节性T细胞的影响[J]. 山东大学学报(医学版), 2010, 48(5): 101-104. |
[14] | 许艳静,郭淑兰. FOXP3在正常人皮肤和表皮肿瘤中的表达及意义[J]. 山东大学学报(医学版), 2010, 48(3): 149-151. |
[15] | 张爱军1,侯明2,孙念政1,魏伟1,张红1,鞠秀丽1. 靛玉红诱导免疫性血小板减少性紫癜小鼠免疫耐受机制的研究[J]. 山东大学学报(医学版), 2010, 48(12): 42-. |
|